Accuray reported $-685K in EBITDA for its fiscal quarter ending in September of 2024.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 26.8M 480K Sep/2026
Boston Scientific USD 1.63B 27M Jun/2026
Edwards Lifesciences USD 562.2M 6.6M Jun/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Tandem Diabetes Care USD 18.04M 11.62M Sep/2026
Trinity Biotech USD -9.6M 7.64M Dec/2024